10.36
price down icon1.80%   -0.19
pre-market  Vorhandelsmarkt:  10.50   0.14   +1.35%
loading

Finanzdaten der Relay Therapeutics Inc-Aktie (RLAY)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
7.00
- 0.677 7.679 -
Operating Expenses
15.87%
67.63
80.39 77.52 92.55 84.98
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
15.87%
67.63
80.39 77.52 92.55 84.98
Operating Income/Loss
24.58%
-60.63
-80.39 -76.85 -84.87 -84.98
Income/Loss From Continuing Operations Before Tax
109.44%
7.00
-74.15 -70.38 -77.06 -
Income/Loss From Continuing Operations After Tax
25.97%
-54.89
-74.15 -70.38 -77.06 -76.00
Net Income/Loss
25.97%
-54.89
-74.15 -70.38 -77.06 -76.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.64%
0.6127
172.39 171.26 169.23 8.2161
Basic Earnings Per Share
27.91%
-0.31
-0.43 -0.41 -0.46 -0.42
Diluted Earnings Per Share
27.91%
-0.31
-0.43 -0.41 -0.46 -0.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):